Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Glioblastoma × regorafenib × Clear all

Phase

Phase 2 3 Phase 2/3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 13 Colorectal Neoplasms 9 Neoplasm Metastasis 3 Leukemia, Myeloid, Acute 3 Sarcoma, Ewing 2 Rectal Neoplasms 2 Myelodysplastic Syndromes 2 Colonic Neoplasms 2 Wilms Tumor 1 Thrombocytosis 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Rhabdomyosarcoma 1 Renal Insufficiency 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Pretreated Metastatic Colorectal Cancer 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Metastatic Solid Malignancies 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Accelerated Phase 1

Interventions

Temozolomide 99 Radiotherapy 56 Radiation 26 Bevacizumab 17 Magnetic Resonance Spectroscopy 13 Nivolumab 11 Irinotecan 10 Cyclophosphamide 9 Surgical Procedures, Operative 8 Specimen Handling 8 pembrolizumab 7 motexafin gadolinium 7 Radiotherapy, Intensity-Modulated 7 Radiosurgery 7 O(6)-benzylguanine 7 Flucytosine 7 Chemotherapy, Adjuvant 7 sargramostim 6 poly ICLC 6 Leukapheresis 6 Erlotinib Hydrochloride 6 Carmustine 6 fludarabine 5 Radiotherapy, Conformal 5 Lomustine 5 Imiquimod 5 Imatinib Mesylate 5 Hydroxyurea 5 Drug Therapy 5 vocimagene amiretrorepvec 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06095375 2026-01-09

REGOMA-2

Istituto Oncologico Veneto IRCCS

Phase 1 Completed

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡